Methotrexate
Methotrexate is an antimetabolite and immunosuppressant medicine used to treat certain cancers, rheumatoid arthritis, psoriasis, and other autoimmune or inflammatory conditions. It works by inhibiting dihydrofolate reductase and affecting folate-dependent cellular processes, reducing DNA synthesis and the activity of rapidly dividing cells and immune cells. It is available as oral tablets, injectable solutions, and prefilled syringes, depending on the indication. Common side effects include nausea, mouth ulcers, fatigue, and reduced blood-cell counts. Important precautions include regular monitoring of blood counts, liver function, and kidney function, as well as awareness of serious risks such as liver injury, bone-marrow suppression, and lung toxicity. For most non-cancer indications, methotrexate is taken once weekly, not daily, and requires strict medical supervision; it is contraindicated during pregnancy for many indications.
Methotrexate was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Methotrexate, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Methotrexate from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Methotrexate, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
